BiotechTube
Home/Respiratorius/Karin Wehlin
KW

Karin Wehlin

Chairman of the Board

Respiratorius

Therapeutic Areas

OncologyHematology

Respiratorius Pipeline

DrugIndicationPhase
VAL001Diffuse Large B-cell Lymphoma (DLBCL)Phase 2

Leadership Team at Respiratorius

JD
Johan Drott
CEO
KD
Kristina Drott
Board Member
ML
Mia Lundblad
Board Member
View full Respiratorius profile